These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 8543314

  • 1. Cell kinetic study of thymic epithelial tumors using PCNA (PC10) and Ki-67 (MIB-1) antibodies.
    Yang WI, Efird JT, Quintanilla-Martinez L, Choi N, Harris NL.
    Hum Pathol; 1996 Jan; 27(1):70-6. PubMed ID: 8543314
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Optimization of immunohistochemical staining of proliferating cells in paraffin sections of breast carcinoma using antibodies to proliferating cell nuclear antigen and the Ki-67 antigen.
    Yu CC, Dublin EA, Camplejohn RS, Levison DA.
    Anal Cell Pathol; 1995 Jul; 9(1):45-52. PubMed ID: 7577754
    [Abstract] [Full Text] [Related]

  • 6. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis.
    Cheville JC, Terrell RB, Cohen MB.
    Mod Pathol; 1994 Sep; 7(7):794-800. PubMed ID: 7824516
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analysis of response to radiation therapy of patients with cervical adenocarcinoma compared with squamous cell carcinoma. MIB-1 and PC10 labeling indices.
    Oka K, Nakano T, Hoshi T.
    Cancer; 1996 Jun 01; 77(11):2280-5. PubMed ID: 8635096
    [Abstract] [Full Text] [Related]

  • 11. Proliferative activity and apoptosis in thymic epithelial neoplasms.
    Hiroshima K, Iyoda A, Toyozaki T, Supriatna Y, Shibuya K, Shimamura F, Haga Y, Yoshida S, Fujisawa T, Ohwada H.
    Mod Pathol; 2002 Dec 01; 15(12):1326-32. PubMed ID: 12481014
    [Abstract] [Full Text] [Related]

  • 12. PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings.
    Serio G.
    Pathologica; 1994 Apr 01; 86(2):161-6. PubMed ID: 7936759
    [Abstract] [Full Text] [Related]

  • 13. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome.
    Delahunt B, Bethwaite PB, Thornton A, Ribas JL.
    Cancer; 1995 Jun 01; 75(11):2714-9. PubMed ID: 7743475
    [Abstract] [Full Text] [Related]

  • 14. MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas.
    Pich A, Ponti R, Valente G, Chiusa L, Geuna M, Novero D, Palestro G.
    J Clin Pathol; 1994 Jan 01; 47(1):18-22. PubMed ID: 7907607
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index.
    Khine MM, Aung W, Sibbons PD, Howard CV, Clapham E, McGill F, Van Velzen D.
    Lab Invest; 1994 Jan 01; 70(1):125-9. PubMed ID: 7905542
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.